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List of abbreviations used in this paper:  
FGT – female genital tract 
ASC – pathogen-specific antibody-secreting cell 
CLA – cutaneous lymphocyte antigen 
HR – homing receptor 
CCR – chemokine receptor 
PLN – peripheral lymph node 
ISC – immunoglobulin-secreting cell 
 
HIGHLIGHTS  
(Circulating pathogen-specific plasmablasts in female patients with upper genital tract 
infection) 
 
- Pathogen-specific plasmablasts appear in the human circulation in upper FGT 
infection 
- The FGT-related ASC response is dominated by IgA rather than IgG ASC.  
- The expression of α4β7, L-selectin, and CLA on ASC is similar in FGT and urinary 
tract infections, suggesting a unique homing receptor profile characteristic of the 
urogenital tract.   






















Mucosal antibodies constitute the first line of adaptive immune defence against invaders in 
the female genital tract (FGT), yet the sequence of events leading to their production is 
surprisingly poorly characterized. We explored the induction of pathogen-specific antibody-
secreting cells (ASC) as a response to an acute infection in the upper FGT.  
We recruited 12 patients undergoing surgery due to an upper FGT infection (7/12 blood 
culture positive, 5/12 negative) and six healthy controls. Pathogens were sampled during 
surgery and PBMC collected in the acute phase of the disease (day 7-10). We searched 
by ELISPOT circulating pathogen-specific ASC and explored their frequency, 
immunoglobulin isotype distribution, and expressions of homing receptors (α4β7, L-selectin, 
and CLA).  
All patients had circulating ASC specific to the infective bacteria; the geometric mean 
was 434 (95%CI 155-1234) ASC (IgA + IgG + IgM) / 106 PBMC. IgA ASC predominated in 
7/12, IgG ASC in 3/12, and IgM ASC in 2/12 cases. Of all the pathogen-specific ASC, 60% 
expressed α4β7, 67% L-selectin, and 9% CLA.  
This study is the first to show induction of pathogen-specific ASC in the peripheral 
blood in bacterial infection in the human FGT. Our findings reveal that such FGT-
originating pathogen-specific ASC are predominated by IgA ASC and exhibit a homing 
receptor profile resembling that of ASC in acute urinary tract infection. The data thus 
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The female genital tract (FGT) is uniquely challenged to provide protection against 
pathogens without compromising reproduction. The FGT comprises upper (Fallopian 
tubes, uterus, endocervix) and lower (ectocervix, vagina) parts, each harbouring a 
characteristic immune defence influenced by hormonal changes (Wira et al. 2015). 
Mucosal antibodies act as key players providing the first specific line of defence against a 
variety of pathogens (Woof and Mestecky, 2005). Nonetheless, the induction of specific 
antibody response in the human FGT is insufficiently characterized as yet.  
An antigen encountered at mucosal sites activates its cognate naïve B lymphocytes 
which enter the lymphatics and return, via blood circulation, to mucosal sites (Brandtzaeg 
and Johansen, 2005, Sigmundsdottir and Butcher, 2008). Consistent with this migration, 
effector B cells, plasmablasts, can be found in the human circulation after mucosal antigen 
encounter: circulating antigen-specific antibody-secreting cells (ASC) have been reported 
after oral (Czercinsky et al.1987; Kantele, 1990; Kantele et. al. 1986), rectal (Kantele et al. 
1998; Kutteh et al. 2001), or intranasal vaccinations (Quiding-Järbrink et al.1997), and in 
various mucosal infections such as gastroenteritis (Kantele et al. 1988, 2008; Kantele JM 
et al. 1996a; Pakkanen et al. 2010), pyelonephritis and cystitis (Kantele et al. 1994, 2008), 
and tonsillitis, sinusitis, and pneumonia (Palkola et al. 2012, 2016). Thus far, circulating 
plasmablasts have not been explored in acute bacterial infection in the genital tract. 
Homing of lymphocytes from circulation into tissues is a selective process where 
tissue-specific homing receptors (HR) and chemokine receptors (CCR) on the circulating 
cells recognize their respective ligands in the target tissue (Brandtzaeg and Johansen, 
2005; Sigmundsdottir and Butcher, 2008). Tissue-specific HR have been identified:  













(PLN) (Camerini et al. 1989), and cutaneous lymphocyte antigen (CLA) to cutaneous sites 
(Berg et al. 1991). Lymphocytes typically home back to sites where the antigen was 
initially encountered (Sigmundsdottir and Butcher, 2008). Accordingly, after intestinal 
antigen encounter, a high proportion of plasmablasts express  and lower proportions 
L-selectin (Kantele et al. 1997; Kantele JM et al. 1996a; Quiding-Järbrink et al. 1997) or 
CLA (Kantele et al. 2003), while antigen encounter at other mucosal sites elicits a different 
homing profile (Kantele et al. 2008; Palkola et al. 2015, 2016; Quiding-Järbrink et al. 
1997). Likewise, in mice, the set of receptors operating in the homing process differs 
between the various mucosal sites (e.g. nasal vs. intestinal) (Csencsits et al. 1999). There 
is, however, a lack of data on HR expressions associated with antigen encounter in the 
FGT.  
We sought to identify circulating FGT-originating plasmablasts in patients with acute 
bacterial infection in the upper FGT. We explored ASC specific to bacteria isolated from 
the site of infection and characterized the response in terms of magnitude, isotype 
















2.1. Study design 
We investigated circulating plasmablasts (pathogen-specific ASC and all immunoglobulin-
secreting cells, ISC) and their homing potentials in patients with bacterial upper FGT 
infection and healthy controls (Fig. 1). 
PBMC were analyzed for ASC and ISC by ELISPOT. Immunomagnetic cell sorting 
was combined with ELISPOT to determine their expression of HR. Samples for bacterial 
cultures were obtained during surgery and the bacteria applied as an antigen to detect 
pathogen-specific ASC.  
The Ethics Committee of Helsinki University Hospital approved the study protocol 
(411/E5/02). Written informed consent was obtained from volunteers.  
  
2.2. Study subjects 
A total of 12 patients (aged 18 to 51) with acute bacterial upper FGT infection were 
recruited at Helsinki University Hospital (Table 1). Blood culture proved positive for 7/12 
(invasive) and negative for 5/12 (non-invasive) patients. Six healthy volunteers (35 to 47 
years) served as controls.  
 
2.3. Sorting of PBMC by homing receptor expression  
PBMC were sorted into HR+ and HR- cell populations by immunomagnetic cell sorting as 
described earlier (Kantele et al. 1997; Kantele JM et al. 1996b). In brief, mAbs specific to 
L-selectin (Leu-8), α4β7 (ACT-1), or CLA (HECA-452) were incubated with PBMC. After 













added to separate HR+ from HR- cells. The efficiency of the separation has been reported 
previously (Kantele et al. 1997). 
 
2.4. Enumeration of ASC and ISC  
Unsorted PBMC and subpopulations HR+ and HR- were analyzed for pathogen-specific 
ASC and ISC by ELISPOT, as described earlier (Kantele, 1990). Briefly, for ASC, each 
patients’ own bacterial isolate or panel of these isolates (healthy controls) was used to 
coat microtiter plate wells. The isolates were applied as suspensions of formalin-killed 
whole bacteria (8 x 106 bacteria / mL PBS; 50 μL / well for three hours at 37ºC or overnight 
at 20ºC). For controls, coating suspensions of six patients were tested, each in their 
individual wells. The concentration of the coating antigen was thus the same for patients 
and controls. For ISC, human IgA, IgM, (Dako, Glostrup, Denmark), or IgG (Sigma, 
Immuno Chemicals, St. Louis, MO) -specific antisera were used for coating. After 
washings and blocking, aliquots of unsorted PBMC or HR+ and HR- subpopulations were 
allowed to secrete antibodies in the wells. Next, alkaline phosphatase-conjugated anti-
human IgA, IgG (Sigma) or IgM (Southern Biotech, Birmingham, AL) were added, followed 
by the substrate (5-bromo-4-chloro-3-indolyl phosphate, Sigma) in melted agarose; spots 
were enumerated under a light microscope. 
 
2.5. Statistical analysis  
The numbers of pathogen-specific ASC and all ISC were given as geometric means of 
ASC/ISC (IgA+IgG+IgM) /106 PBMC with 95% confidence intervals (95%CI) as counted 
using bootstrapping in four groups: all patients, blood-culture positive and negative 


















HR expressions were determined as percentages of ASC: 
 % HR+ASC =100 x(number of ASC in HR+ population) /(total of ASC in HR+ and HR- 
populations) 
or ISC:  
% HR+ISC =100 x(number of ISC in HR+ population) / (total of ISC in HR+ and HR- 
populations).  
 
The proportion of ASC or ISC expressing the various HR were given as arithmetic 
means with SD. To obtain reliable statistics in the HR analyses, we only included those 
with ≥ 20 identified spots.  
Independent-samples Mann-Whitney U test and related-samples Wilcoxon Signed 

















3.1. Number of ASC and ISC 
Pathogen-specific ASC (IgA+IgG+IgM) were found in all patients (12/12) (Table 1); the 
geometric mean was 434/106 PBMC (95%CI 155–1234). None of the responses were <10 
ASC, four were in the range 10–100 and 100–1000, three in 1000–10000, and one in 
10000–100000 ASC /106 PBMC (Fig. 2). The figures appeared not to correlate with blood 
culture findings:  those with the lowest responses (20 and 28 ASC /106 PBMC) and the 
one with the highest (11575 ASC) had positive blood cultures; the low-responders were 
both treated at an intensive care unit. The geometric mean of ASC (IgA+IgG+IgM) /106 
PBMC in blood culture positive (7/12) patients was 257 (95%CI 26–4448) and negative 
(5/12) 903 (68–9947) (p=0.343). The healthy volunteers had no ASC response specific to 
the pool of pathogens.  
The geometric mean for all ISC (IgA+IgG+IgM) was higher in the patients than in 
healthy controls (p<0.0001) (Fig. 2). The frequency of ISC was similar in invasive and non-
invasive cases (p=0.876) (Fig. 2).  
 
3.2. Isotype distributions of ASC and ISC  
The geometric mean for IgA ASC was 140 (95%CI 28–866) /106 PBMC, for IgG ASC 103 
(22–405), and for IgM ASC 50 (13–181) (Fig. 3A). IgA ASC were detected in all patients; 
one patient had no IgG and another no IgM ASC. IgA ASC predominated in 7/10 and IgG 
in 3/10 patients with the highest responses and IgM in the two low-responders (Fig. 3A).  
Circulating ISC were seen in all three isotypes for all subjects, implying that none of the 













means of IgA, IgG, and IgM ISC among patients (B) and healthy controls (C). IgG ISC 
predominated for 11/12 patients and all controls, and IgA ISC for one patient (Fig. 3B and 
C).  
 
3.3. Expression of α4β7, L-selectin, and CLA on pathogen-specific ASC and all ISC 
When the data of all patients (invasive and non-invasive cases) were pooled, the 
proportion of ASC (IgA+IgG+IgM) ±SD expressing α4β7 was 60% ±27, L-selectin 67% ±22, 
and CLA 9.0% ±6.7 (Fig. 4). HR-expressions did not differ by isotype of ASC (data not 
shown).  
Figure 5 shows HR expressions for invasive vs. non-invasive infections. L-selectin-
expressing ASC appeared more frequent in invasive (77% ±14) than non-invasive (55% 
±26) infections, but the difference was non-significant (p=0.177). As for α4β7 and CLA, the 
proportions were similar in the two groups (p=1.00 for both) (Fig. 5).  
HR expressions of patients’ ISC resembled those of the same patients’ ASC and 
those of healthy controls’ ISC (Fig. 4). No difference was seen in HR expressions between 
the ISC of those with invasive and non-invasive infections; 57% ±25 vs. 60% ±8 for α4β7 














4.  DISCUSSION 
 
4.1. Introduction 
This is the first study to show that pathogen-specific plasmablasts emerge in the human 
circulation in response to acute bacterial upper FGT infection, a result according with 
previous findings for infections at other mucosal sites (Kantele et al. 1988, 1994; Palkola et 
al. 2012, 2016). Detecting such cells also in upper FGT infections encourages their use as 
tools for evaluating immune responses in the FGT.  
 
4.2. Timing of sampling  
As plasmablasts only circulate transiently before homing into their target tissues, sampling 
timing is critical. We utilized our previous experience of acute mucosal infections in the 
urinary (Kantele et al. 2008) and respiratory tracts (Palkola et al. 2012, 2016), and the gut 
(Kantele et al.1988), and the kinetics of plasmablasts in the circulation as reported in 
gastroenteritis (Kantele, 2012) and after oral (Kantele, 1990,1991; Kantele et al. 1986) and 
rectal vaccinations (Kantele et al. 1998). Antigen-specific plasmablasts enter the blood 
approximately on the third day after antigen encounter, peak in frequency on day seven, 
and disappear gradually by days 14–16. Prolonged antigenic stimulus may lengthen the 
detection period (Kantele, 1991, 2012).  Accordingly, to catch the peak of the response, 
we only recruited patients with a history of symptoms lasting 7–10 days. The timing proved 
















4.3. Numbers of circulating plasmablasts (ASC and ISC)  
The vigorous ASC response reveals the remarkable inductive capacity of the upper FGT, 
consistent with previous reports (Wira, 2015; Iwasaki, 2010). Indeed, the magnitude of the 
response exceeded that seen in infections of the upper (Palkola et al. 2016) and lower 
(Palkola et al. 2012) respiratory tracts, yet resembled that in infections at anatomically 
close sites i.e. gastroenteritis (Kantele et al.1988) or upper urinary tract infection (UTI) 
(Kantele et al. 2008).  
As for ISC, representing the total of all ASC subpopulations at the time of sampling, 
the numbers proved exceptionally high: they exceeded by far those of ISC in healthy 
volunteers, even with the increase caused by pathogen-specific ASC taken into account. 
The high ISC frequency accords with previous reports on gastroenteritis (Kantele et al. 
1988), respiratory tract infections (Palkola et al. 2012, 2016), and upper but not lower UTI 
(Kantele et al. 1994). As explanation, we have suggested polyclonal stimulation associated 
with severe natural infections (Kantele et al. 1988; Palkola et al. 2012). According with our 
findings, human memory B lymphocytes have been shown to differentiate into plasma cells 
in response to polyclonal stimuli, such as microbial products or bystander T cell help. 
Specific antibody-secreting cells have been found in such settings even in the absence of 
their cognate antigen (Bernasconi et al. 2002).  
 
4.4. Immunoglobulin isotype distribution of pathogen-specific plasmablast 
response  
While IgA predominated in the pathogen-specific plasmablast responses, also IgG ASC 
were abundant. Indeed, pathogen-specific IgA and IgG ASC have been shown to 
accumulate in the genital tract as a response to mucosal immunization or infection in 













humans (Kutteh et al. 1990). Both isotypes can contribute to protection against sexually-
transmitted pathogens (Bomsel et al. 2011; Li et al. 2011; Mascola 2000; Shin and Iwasaki 
2013). The high IgA ASC numbers accord not only with the previously reported upstream 
increase of IgA levels in FGT secretions (Kozlowski 2002; Quesnel et al. 1997), and 
predominance of IgA ASC in mucosae of the upper FGT (Kutteh et al. 1990), but also the 
active IgA transport (pIgR) operating on the epithelium of upper FGT (Iwasaki, 2010). 
Moreover, IgA is the general mucosal isotype, predominating among the circulating 
pathogen-specific ASC in gastroenteritis (Kantele et al. 1988; Kantele JM et al. 1996a; 
Pakkanen et al. 2010) and upper UTI (Kantele et al. 2008), and after oral vaccination 
(Kantele 1990; Kantele et al. 1986, Pakkanen et al 2010). Like the high IgG ASC numbers 
in this study, high IgG antibody levels have been associated with FGT, and the 
mechanisms transporting IgG (nFcR) exist throughout the FGT (Li et al. 2011). Indeed, in 
human cervico-vaginal secretions, IgG levels even exceed those of IgA (Li et al 2011; 
Kozlowski et al. 2002). 
 
4.5. Homing profiles of plasmablasts   
Homing molecules directing lymphocytes into the human FGT have been poorly described. 
Studies with rodents report recruitment of IgA cells into the uterus by the CCR10-CCL28 
interaction (Cha et al. 2011; Cuburu et al. 2009). As for T lymphocytes, a unique memory-
T-cell population co-expressing α4β7 and CLA has been detected in the endocervix of 
patients with Chlamydia infection (Kelly et al. 2009), and ligands such as E-selectin (ligand 
to CLA), ICAM-1, and VCAM-1 have been proved inducible on human endometrium 
(Tabibzadeh et al. 1994). Moreover, α4β1-integrin-expressing T cells have been found in 
infected murine FGT (Davila et al. 2014). For the present study of circulating plasmablasts 













markers have been extensively explored in infections of other mucosal sites (Kantele et al. 
2008, Kantele JM et al. 1996a; Palkola et al. 2015, 2016; Pakkanen et al. 2010).  
 
4.6. General characteristics of HR profile 
α4β7 and L-selectin were both expressed on two thirds of the circulating pathogen-specific 
plasmablasts and CLA on only a small proportion. Such a HR profile implies that α4β7 and 
L-selectin contribute, but CLA less, in the dissemination of B cells from the upper FGT. 
Although we could not explore plasmablasts in the FGT tissues, this HR profile may, at 
least partly, represent that required for homing to the FGT, as migrating effector 
lymphocytes favour the initial activation site (Sigmundsdottir and Butcher, 2008). It should 
be highlighted that FGT lacks organized structures equivalent to intestinal Payer’s 
patches. Instead, draining lymph nodes (the common iliac, internal iliac, external iliac, and 
the inguinal femoral lymph nodes), may serve directly as activation sites (Iwasaki, 2010). 
The anatomically close rectal and urogenital mucosal sites at least partly share the same 
draining lymph nodes. It is thus of interest to compare the HR profile in FGT infection to 
that of infections in various human anatomical compartments, especially those of the 
intestinal and urinary tract. 
 
4.6.1. Comparison with intestinal HR profile 
The HR profile of circulating ASC in the upper FGT infection differed from the gut-seeking 
profile with respect to α4β7: although substantial, the proportion of α4β7-expressing cells 
(60%) did not reach that of gut-seeking lymphocytes (90–100%) reported after oral 
immunization (Kantele et al. 1997; Quiding-Järbrink 1997) and in acute gastroenteritis 
(Kantele JM et al. 1996a; Palkola et al. 2008). The main ligand for α4β7, mucosal cell 













1997), whereas in FGT, MadCAM-1 expression has only been reported in tissue culture 
models of chlamydia infection (Kelly et al. 2001), not in non-infection settings (Johansson 
et al. 1999). L-selectin, on the other hand, may figure more importantly in infections of the 
FGT (67%) than the intestine (40%; Kantele et al. 2008; Kantele JM et al. 1996a). L-
selectin-expressing plasmablasts dominate a systemic profile (proportion of L-selectin 
high, α4β7 moderate and CLA low) induced in PLN after parenteral immunization (Kantele 
et al. 1997; 2008; Quiding-Järbrink et al. 1997). The substantial proportion of L-selectin-
expressing cells in FGT infections may reflect both the systemic part of the immune 
protection and a contribution of L-selectin in targeting effector B cells into the FGT. We are 
unaware of any studies exploring whether the ligand of L-selectin, peripheral lymph node 
addressin (PNAd), is abundant within the FGT.  
  
4.6.2. Comparison with HR profile in respiratory tract 
It is interesting to compare the HR profiles of the FGT and the respiratory tract, for a cross-
talk has been reported between nasal and genital surfaces (Johansen et al. 2005; 
Kozlowski et al. 2002). Antigen-specific ASC and cell-mediated immune responses have 
been reported in murine/primate FGT after intranasal (Cha et al. 2011; Johansson 1998) 
and sublingual (Cuburu et al. 2009) immunizations. Accordingly, in line with our data, a 
high to moderate proportion of both L-selectin- and α4β7-expressing ASC has been shown 
after intranasal cholera vaccination in humans (Quiding-Järbrink et al. 1997). In contrast, in 
respiratory tract infections (sinusitis, tonsillitis, pneumonia) the proportion of L-selectin-
expressing cells appears higher (79–82%) and that of α4β7-expressing cells lower (15–
44%) than in upper FGT infections (67% and 60%, respectively) (Palkola et al. 2015, 
2016). The slight differences between the HR profiles reported for tonsillitis and sinusitis 













intranasal immunization only stimulating a restricted area in the Waldeyer’s ring (resulting 
in high α4β7 proportions) and natural infections impacting more scattered induction sites.  
 
4.6.3. Comparison with HR profile for UTI 
A comparison with the urinary tract is of interest, as it may share draining lymph nodes 
with FGT. Indeed, the homing profile of pathogen-specific ASC in acute upper UTI (α4β7 
61%, L-selectin 51%, CLA 13%) (Kantele et al. 2008) clearly resembles that found for 
FGT. The present HR profile (high to moderate proportion of α4β7 and L-selectin, and low 
of CLA-expressing cells) might thus represent one shared by the urogenital area. 
 
4.7. Limitations 
Three limitations should be mentioned: small number of subjects, limited coverage of 
various homing markers, and the fact that we did not assess the possible effect of 
hormonal status. Future studies should cover other potential receptors and the impact of 
hormonal status on HR expression. 
 
4.8. Conclusions 
This study is the first to show that pathogen-specific plasmablasts appear in the circulation 
in response to bacterial infection in the upper FGT, the response predominated by IgA, 
followed by IgG and IgM plasmablasts. These circulating cells provide a tool for future 
investigations seeking to noninvasively explore immune responses elicited at this site. A 
homing profile resembling that reported previously for the upper urinary tract was revealed, 
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Fig. 2. Numbers of pathogen-specific ASC and all ISC 
The numbers of (IgA + IgG + IgM) ASC and -ISCs /106 PBMC in the peripheral blood are 
given individually for the 12 female patients with bacterial upper genital tract infection, and 
6 healthy controls. The patients were examined 7–12 days after onset of symptoms. Open 
triangles indicate non-invasive and black ones invasive cases. Horizontal lines show 
geometric means. The numbers proved higher in patients than controls when tested with 














Fig. 3. Ig isotype distributions of pathogen-specific ASC and all ISC  
Triangles represent the number of pathogen-specific IgA, IgG or IgM ASC (A) or ISC (/106 
PBMC) in the circulation of patients with upper genital tract infection (B) and healthy 
controls (C). Individual patients’ results are joined with a line; open triangles indicate non-
invasive and black ones invasive cases. Horizontal lines show geometric means (n=12 for 
patients and 6 for controls). 
 
Fig. 4.  Proportions of α4β7-, L-selectin-, and CLA-expressing cells among ASC and 
ISC  
The bars indicate the means of the percentages of ASC or ISC expressing the given HR 













subjects from whom the data were pooled is indicated under each bar. The proportions of 
cells expressing α4β7, L-selecting and CLA were similar in comparisons (Related-samples 
Wilcoxon Signed Rank test for ASC vs. ISC of patients; Independent-samples Mann-
Whitney U test for ASC/ ISC of patients vs. ISC of controls). 
 
Fig. 5. Expression of α4β7, L-selectin, and CLA on pathogen-specific ASC in acute 
invasive and non-invasive female reproductive tract infection  
The bars indicate arithmetic means with SD of percentages of cells expressing the given 
HR among ASC (IgA + IgG+ IgM). The number of patients for whom the data were pooled 
is indicated under each bar. The proportions of α4β7-, L-selectin-, and CLA-expressing cells 
appeared similar in the invasive and non-invasive groups (Independent-samples Mann-




























a number of days between onset of symptoms and blood sample  
b (IgA + IgG + IgM) ASC  































1.1 23 Salpingitis Escherichia coli 7 39 189 9 947 82 6 12 
1.2 45 Salpingitis Staphylococcus aureus 8 38.6 178 1 164 13 75 12 
1.3 42 Salpingitis Bacteroides fragilis 8 39 250 785 52 31 17 
1.4 43 Salpingitis Escherichia coli 12 >39 360 68 44 25 31 
1.5 40 Salpingitis Escherichia coli 7 NAc NA 971 50 34 16 
Invasive 
2.1 26 Chorioamnionitis Haemophilus influenzae 8 38,7 135 2 757 6 74 20 
2.2 25 Chorioamnionitis Streptococcus pyogenes 7 38 110 65 61 39 0 
2.3 42 Chorioamnionitis Streptococcus pyogenes  8 NA NA 468 81 18 1 
2.4 38 Endometritis Streptococcus pyogenes  9 >39 >200 135 19 78 3 
2.5 51 Endometritis Escherichia coli 9 NA NA 11 575 86 7 7 
2.6 23 Chorioamnionitis Eikenella corrodens 7 NA NA 28 14 21 65 
2.7 18 Chorioamnionitis Streptococcus pyogenes  9 >39 300 20 16 0 84 AC
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